Overview
Daniela Chao-Moro practices practicing medicine in Amsterdam, Netherlands.
Her clinical expertise encompasses Farber Lipogranulomatosis, Obesity, and Low Blood Sugar.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Daniela Chao-Moro
Is Daniela Chao-Moro a top-rated expert for Farber Lipogranulomatosis?
MediFind is an objective health platform that identifies experts based on real-world data. Daniela Chao-Moro is classified as an Experienced expert for Farber Lipogranulomatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Daniela Chao-Moro participate in research or clinical trials?
Yes. Daniela Chao-Moro has published 8 articles and abstracts on conditions like Farber Lipogranulomatosis. You can view a list of Daniela Chao-Moro's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Farber LipogranulomatosisMs. Chao-Moro isExperienced. Learn about Farber Lipogranulomatosis.
- Low Blood SugarMs. Chao-Moro isExperienced. Learn about Low Blood Sugar.
- ObesityMs. Chao-Moro isExperienced. Learn about Obesity.